Current consensus guidelines for treatment of neurocysticercosis (Q24535667)

Armando Emiliano González

Europe PubMed Central

title

Current consensus guidelines for treatment of neurocysticercosis (English)

0 references

1 reference

Armando E Gonzalez

16

Armando E

Gonzalez

1 reference

20 October 2023

A Clinton White

5

A Clinton Jr

White

1 reference

20 October 2023

Ana Flisser

11

Ana

Flisser

1 reference

20 October 2023

17

Robert H Gilman

Robert H

Gilman

1 reference

20 October 2023

13

Elsa Sarti

Elsa

Sarti

1 reference

20 October 2023

3

Theodore E Nash

Theodore E

Nash

1 reference

20 October 2023

Hector H García

1

Hector H

García

1 reference

20 October 2023

Carlton A W Evans

2

Carlton A W

Evans

1 reference

20 October 2023

Osvaldo M Takayanagui

4

Osvaldo M

Takayanagui

1 reference

20 October 2023

David Botero

6

David

Botero

1 reference

20 October 2023

Vedantam Rajshekhar

7

Vedantam

Rajshekhar

1 reference

20 October 2023

Victor C W Tsang

8

Victor C W

Tsang

1 reference

20 October 2023

Peter M Schantz

9

Peter M

Schantz

1 reference

20 October 2023

James C Allan

10

James C

Allan

1 reference

20 October 2023

Dolores Correa

12

Dolores

Correa

1 reference

20 October 2023

Jon S Friedland

14

Jon S

Friedland

1 reference

20 October 2023

S Manuel Martinez

15

S Manuel

Martinez

1 reference

20 October 2023

Oscar H Del Brutto

18

Oscar H

Clinical Microbiology Reviews

Del Brutto

1 reference

20 October 2023

language of work or name

English

0 references

publication date

October 2002

0 references

published in

0 references

volume

15

0 references

page(s)

747-56

0 references

issue

4

0 references

cites work

Proposed diagnostic criteria for neurocysticercosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Morphological types of Taenia solium cysticerci.

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Seizure recurrence in children with focal seizures and single small enhancing computed tomographic lesions: prognostic factors on long-term follow-up

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Taenia solium cysticercosis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Endoscopic management of cysticercal cysts within the lateral and third ventricles

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Cysticercosis and epilepsy: a critical review.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Therapy for neurocysticercosis: a reappraisal.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Cysticercosis of the central nervous system. II. Spinal cysticercosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Treatment of cysticercosis with praziquantel at the Bangkok Hospital for Tropical Diseases

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Anticysticercous antibodies in serum and cerebrospinal fluid in patients with cerebral cysticercosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Cerebral cysticercosis: documentation of natural history with CT.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Treatment of neurocysticercosis: is praziquantel the new hope?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Etiology and management of single small CT lesions in patients with seizures: understanding a controversy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Extraparenchymal neurocysticercosis: report of five cases and review of management

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Taenia solium cysticercosis: host-parasite interactions and the immune response

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Endoscopic removal of cysticercal cysts within the fourth ventricle. Technical note

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Intramedullary cysticercosis cured with drug treatment. A case report.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Severe forms of neurocysticercosis: treatment with albendazole.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

The use of albendazole in patients with single lesions enhanced on contrast CT.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Neurocysticercosis in Houston, Texas. A report of 112 cases.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Albendazole therapy for neurocysticercosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Treatment of cysticercosis with praziquantel in Colombia.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

A prognostic classification of cerebral cysticercosis: therapeutic implications

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Results of surgical treatment of neurocysticercosis in 69 cases.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Neurocysticercosis: surgical and medical management with praziquantel.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Praziquantel (pyrazinoisoquinolone) in active cerebral cysticercosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Neurocysticercosis. Short course of treatment with albendazole

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Ocular cysticercosis, typical forms and treatment

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Disappearing CT lesions in Indian patients with epilepsy

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Antihelminthic therapy for neurocysticercosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Total recovery of visual function after treatment for cerebral cysticercosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Epilepsy due to neurocysticercosis: analysis of 203 patients.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Albendazole therapy for giant subarachnoid cysticerci

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Therapy for neurocysticercosis. Comparison between albendazole and praziquantel

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

The course of seizures after treatment for cerebral cysticercosis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Seizures and treatment for cerebral cysticercosis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

The racemose form of cerebral cysticercosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Optimization of the single-day praziquantel therapy for neurocysticercosis

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Albendazole therapy for solitary persistent cysticercus granuloma

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Short regimen of praziquantel in the treatment of single brain enhancing lesions.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Single-day praziquantel versus 1-week albendazole for neurocysticercosis.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Endoscopic removal of a third ventricular cysticercal cyst.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Albendazole therapy for giant subarachnoid cysticerci.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Treatment of neurocysticercosis with a two week course of albendazole.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Cerebral cysticercosis treated biphasically with dexamethasone and praziquantel.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Spontaneous radiographic disappearance of cerebral cysticercosis: three cases.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Medical management of neurocysticercosis with Praziquantel.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Plasma levels of praziquantel decrease when dexamethasone is given simultaneously.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=126865

Taeniasis and cysticercosis due to Taenia solium

29 November 2018

1 reference

12 December 2020

Administration of praziquantel in neurocysticercosis

1 reference

12 December 2020

Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 1. Radiological, physiological and histopathological studies

1 reference

12 December 2020

Single-day praziquantel therapy for neurocysticercosis

1 reference

12 December 2020

Neurocysticercosis: focus on intraventricular disease

1 reference

12 December 2020

Albendazole therapy for neurocysticercosis

1 reference

12 December 2020

Dexamethasone increases plasma levels of albendazole

1 reference

12 December 2020

Parenchymal neurocysticercosis: follow-up and staging by MRI

1 reference

12 December 2020

Praziquantel for cysticercosis of the brain parenchyma

1 reference

12 December 2020

Neurocysticercosis: treatment with albendazole and dextrochloropheniramine (preliminary report)

1 reference

12 December 2020

A short praziquantel regimen for the treatment of parenchymatous neurocysticercosis

1 reference

12 December 2020

Is the course of neurocysticercosis modified by treatment with antihelminthic agents?

1 reference

12 December 2020

A follow-up study of 420 cases of cerebral cysticercosis

1 reference

12 December 2020

Cerebral cysticercosis: treatment with praziquantel. Report of two cases

1 reference

12 December 2020

[From cyst to cysticercus granuloma using cranial computerized tomography]

1 reference

12 December 2020

Cysticercosis mimicking brain tumor: the role of albendazole as a diagnostic tool

1 reference

12 December 2020

Short course albendazole treatment for neurocysticercosis in Columbia

1 reference

12 December 2020

[Neurocysticercosis. Treatment with praziquantel. A preliminary study (author's transl)]

1 reference

12 December 2020

Medical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases

1 reference

12 December 2020

Phenytoin and carbamazepine decreased oral bioavailability of praziquantel

1 reference

12 December 2020

Albendazole in single CT ring lesions in epilepsy

1 reference

12 December 2020

Medical treatment of cysticercosis: ineffective vs effective

1 reference

12 December 2020

High-dose praziquantel for neurocysticercosis: efficacy and tolerability

1 reference

12 December 2020

Neurocysticercosis: optimal dose treatment with albendazole

1 reference

12 December 2020

Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy

1 reference

12 December 2020

Report of a clinical case of cerebral cysticercosis treated medically with a new drug: praziquantel

1 reference

12 December 2020

Neurocysticercosis: an update

1 reference

12 December 2020

Medical treatment of cysticercosis--ineffective

1 reference

12 December 2020

Albendazole in neurocysticercosis

1 reference

12 December 2020

Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial

1 reference

12 December 2020

Cysticercosis causing single, small CT lesions in Indian patients with seizures

1 reference

12 December 2020

Possible association of use of bendectin during early pregnancy and congenital lung hypoplasia

1 reference

Crossref

https://api.crossref.org/works/10.1128%2FCMR.15.4.747-756.2002

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1128/CMR.15.4.747-756.2002

1 reference

release_vquv767jhnbgjaqki5xg77s4di

2616395

Fatcat ID

0 references

2616395

1 reference

1 reference

1 reference